You might be too busy to pay much attention to every tiny biotech that goes public. There’s one initial public offering (IPO) coming up, though, that I think you’ll want to keep your eyes on. Jounce Therapeutics filed a few days ago for an IPO in 2017. Any company that Celgene (NASDAQ: CELG) is willing to invest in big-time is one that is worth watching.
Image source: Getty Images.